Search Results - "Chard Dunmall, Louisa S."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Natural products targeting glycolysis in cancer by Zhao, Yuanyuan, Chard Dunmall, Louisa S, Cheng, Zhenguo, Wang, Yaohe, Si, Lingling

    Published in Frontiers in pharmacology (01-11-2022)
    “…Many energy metabolism pathways exist in cancer, including glycolysis, amino acid metabolism, fatty acid oxidation, and mitochondrial respiration. Tumor cells…”
    Get full text
    Journal Article
  2. 2

    Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma by Wang, Zhizhong, Cheng, Zhenguo, Lu, Shuangshuang, Chard Dunmall, Louisa S., Wang, Jun, Guo, Yongjun, Wang, Yaohe

    Published in Frontiers in immunology (22-06-2022)
    “…Esophageal Squamous Cell carcinomas (ESCC) is a highly heterogeneous malignancy that is among the leading cause of cancer-related death worldwide. B cells play…”
    Get full text
    Journal Article
  3. 3

    Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients by Zhang, Na, Wu, Yangyang, Wu, Yifan, Wang, Lihong, Chen, Jingfei, Wang, Xiaosa, Chard Dunmall, Louisa S, Cheng, Zhenguo, Wang, Yaohe

    Published in Cells (Basel, Switzerland) (15-07-2022)
    “…Background: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSCC) are two of the most common subtypes of non-small cell lung cancer (NSCLC), with…”
    Get full text
    Journal Article
  4. 4

    An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition by Sun, Yijie, Zhang, Zhe, Zhang, Chenglin, Zhang, Na, Wang, Pengju, Chu, Yongchao, Chard Dunmall, Louisa S., Lemoine, Nicholas R., Wang, Yaohe

    Published in Molecular therapy. Oncolytics (15-09-2022)
    “…Glioblastoma (GBM) is the most common primary malignant tumor in the brain, accounting for 51.4% of all primary brain tumors. GBM has a highly…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer by Wang, Na, Wang, Jiwei, Zhang, Zhe, Cao, Hua, Yan, Wenli, Chu, Yongchao, Chard Dunmall, Louisa S., Wang, Yaohe

    Published in Molecular therapy. Oncolytics (26-03-2021)
    “…Colorectal cancer (CRC) is one of the leading causes of mortality and morbidity in the world, and there remains an urgent need to develop long-lasting…”
    Get full text
    Journal Article
  7. 7

    Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene by Cao, Dujuan, Song, Qianqian, Li, Junqi, Chard Dunmall, Louisa S., Jiang, Yuanyuan, Qin, Bin, Wang, Jianyao, Guo, Haoran, Cheng, Zhenguo, Wang, Zhimin, Lemoine, Nicholas R., Lu, Shuangshuang, Wang, Yaohe

    Published in Molecular therapy. Oncolytics (16-06-2022)
    “…Immunotherapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen receptor-T (CAR-T) cells, are only efficient in a small proportion of tumor…”
    Get full text
    Journal Article
  8. 8

    Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment by Wang, Lihong, Chard Dunmall, Louisa S, Cheng, Zhenguo, Wang, Yaohe

    Published in Journal for immunotherapy of cancer (01-05-2022)
    “…Tumor cells manipulate the local environment in which they grow, creating a tumor microenvironment (TME) that promotes tumor survival and metastasis. The TME…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy by Jia, Yangyang, Wang, Yanru, Dunmall, Louisa S Chard, Lemoine, Nicholas R, Wang, Pengju, Wang, Yaohe

    Published in Frontiers in immunology (27-02-2023)
    “…Cancer immunotherapy (CIT) has emerged as an exciting new pillar of cancer treatment. Although benefits have been achieved in individual patients, the overall…”
    Get full text
    Journal Article
  12. 12

    Promising xenograft animal model recapitulating the features of human pancreatic cancer by Miao, Jin-Xin, Wang, Jian-Yao, Li, Hao-Ze, Guo, Hao-Ran, Dunmall, Louisa S Chard, Zhang, Zhong-Xian, Cheng, Zhen-Guo, Gao, Dong-Ling, Dong, Jian-Zeng, Wang, Zhong-De, Wang, Yao-He

    Published in World journal of gastroenterology : WJG (28-08-2020)
    “…Multiple sites of metastasis and desmoplastic reactions in the stroma are key features of human pancreatic cancer (PC). There are currently no simple and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The capability of heterogeneous γδ T cells in cancer treatment by Yan, Wenyi, Dunmall, Louisa S Chard, Lemoine, Nicholas R, Wang, Yaohe, Wang, Yafeng, Wang, Pengju

    Published in Frontiers in immunology (2023)
    “…γδ T cells, a specialized subset of T lymphocytes, have garnered significant attention within the realm of cancer immunotherapy. Operating at the nexus between…”
    Get full text
    Journal Article
  15. 15

    MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy by Baleeiro, Renato B., Bouwens, Christian J., Liu, Peng, Di Gioia, Carmela, Dunmall, Louisa S. Chard, Nagano, Ai, Gangeswaran, Rathistevy, Chelala, Claude, Kocher, Hemant M., Lemoine, Nicholas R., Wang, Yaohe

    Published in Oncoimmunology (31-12-2022)
    “…MHC class II expression is a hallmark of professional antigen-presenting cells and key to the induction of CD4+ T helper cells. We found that these molecules…”
    Get full text
    Journal Article
  16. 16

    Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy by Baleeiro, Renato B., Dunmall, Louisa S. Chard, Liu, Peng, Lu, Shuangshuang, Lone, Yuchun, Lemoine, Nicholas R., Wang, Yaohe

    Published in Frontiers in immunology (26-05-2022)
    “…RAS mutations occur in approximately 20% of all cancers and given their clonality, key role as driver mutation, association with poor prognosis and…”
    Get full text
    Journal Article
  17. 17

    Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer by Brito Baleeiro, Renato, Liu, Peng, Chard Dunmall, Louisa S, Di Gioia, Carmela, Nagano, Ai, Cutmore, Lauren, Wang, Jun, Chelala, Claude, Nyambura, Lydon Wainaina, Walden, Peter, Lemoine, Nicholas, Wang, Yaohe

    Published in Journal for immunotherapy of cancer (01-08-2023)
    “…Triple-negative breast cancer (TNBC) corresponds to approximately 20% of all breast tumors, with a high propensity for metastasis and a poor prognosis. Because…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma by Zhang, Zifang, Zhang, Chunyang, Miao, Jinxin, Wang, Zhizhong, Wang, Zhimin, Cheng, Zhenguo, Wang, Pengju, Dunmall, Louisa S Chard, Lemoine, Nicholas R, Wang, Yaohe

    Published in Cells (Basel, Switzerland) (10-11-2020)
    “…Esophageal squamous cell carcinoma (ESCC) is one of the most lethal cancers in China and existing therapies have been unable to significantly improve…”
    Get full text
    Journal Article